Modafinil in Opioid Induced Sedation

Summary

* The primary objective of this study is to evaluate the efficacy of modafinil in the treatment of opioid induced sedation as measured by the Epworth Sleepiness Scale (ESS). * The secondary objective is to estimate the frequency and severity of toxicity associated with Modafinil (400mg) in patients with opioid induced sedation.

Timeline

Start

2006-01

Primary completion

—

Completion

2006-12

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual”

Drugs

Indications